
Our Mission
PulseMedica is laser-focused on improving the quality of life for millions of people by building revolutionary technology to image and treat vitreoretinal disease.
Backed by Leading Investors

Our Story
PulseMedica's Founding Story
PulseMedica’s story began when Dr. Nir Katchinskiy completed his PhD under the supervision of Prof. Abdulhakem Elezzabi at the University of Alberta. Their research focused on femtosecond laser-tissue interaction.
In 2020, Nir participated in the Creative Destruction Lab - Rockies (CDL-R) program where he met Eric Martin, who was pursuing his MBA at the University of Alberta.
United by their commitment and passion for enacting change for those suffering from eye disease, Abdul, Nir, and Eric co-founded PulseMedica with invaluable guidance and support from CDL-R mentors.
Leadership at PulseMedica
We believe that leadership isn't just a position but a commitment to inspiring, innovating, and empowering others to achieve success. Meet the leadership team at PulseMedica: Nir Katchinskiy, Eric Martin, and Thas Yuwaraj.

Co-Founder/CEO
Dr. Nir Katchinskiy
Nir has a Ph.D. in Biomedical Engineering and is an expert in developing and applying femtosecond laser technology in human tissue. He has designed and developed a methodology for imaging and treating vitreoretinal conditions and continues to drive the exceptional progress of innovation at PulseMedica.

Co-Founder/COO
Eric Martin
Eric has a diverse background as a RN, MBA, Organization Change Management professional and Executive Coach. Eric as a trusted clinician leader, coach and strategist, leads high impact and expansive business developments through supporting the growth of people, processes, and innovation.

Chief Technology Officer
Thas Yuwaraj
Thas is a seasoned healthcare and data science leader with a Ph.D. in Biomedical Engineering. He has experience leading medical device development from concept to commercialization. He brings a holistic approach to product development, leveraging his experience leading engineering, regulatory, quality and IP teams.
What We Strive For
Short-Term Vision
Screen and Treat Symptomatic Eye Floaters
Become the global expert in non-invasive, safe, effective imaging and treatment of floaters.
Long-Term Vision
Address Additional Vitreoretinal Eye Disease
Become the global standard for screening and treating vitreoretinal disease.











.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpeg)







